Badimon J J, Badimon L, Galvez A, Dische R, Fuster V
Division of Cardiology, Mount Sinai School of Medicine, New York, New York.
Lab Invest. 1989 Mar;60(3):455-61.
The effects of in vivo administration of high density lipoprotein-very high density lipoprotein (HDL-VHDL) on the development of aortic fatty streaks were studied in cholesterol-fed rabbits. The rabbits received a 0.5% cholesterol-rich diet for 8 weeks. During this period, the HDL-VHDL group was intravenously administered with 50 mg/week of homologous HDL-VHDL protein; the control group received normal saline (0.9% NaCl). HDL-VHDL fraction was obtained at density range 1.063 to 1.25 gm/ml by ultracentrifugation of normal rabbit plasma. Along the study, plasma lipid levels followed a similar profile in both groups. At the completion of the study, atherosclerotic-like lipid-rich lesions covered 37.9 +/- 6% (X +/- SEM) of the intimal aortic surface in the control group, and 14.9 +/- 2.1% in the treated group (p less than 0.001). The values of total and free cholesterol, esterified cholesterol, and phospholipids deposited within vessel wall were significantly lower in the aortas of the HDL-VHDL treated group than those in the control group. Cholesterol accumulation in the livers was also significantly lower (p less than 0.01) in the treated group than in the control. We concluded that administration of homologous HDL-VHDL lipoprotein fraction to cholesterol-fed rabbits, dramatically inhibited the extent of aortic fatty streaks and lowered lipid deposition in the arterial wall and liver without modification of the plasma lipid levels.
在喂食胆固醇的兔子中研究了体内给予高密度脂蛋白 - 极高密度脂蛋白(HDL - VHDL)对主动脉脂肪条纹形成的影响。兔子接受含0.5%胆固醇的饮食8周。在此期间,HDL - VHDL组静脉注射每周50毫克的同源HDL - VHDL蛋白;对照组接受生理盐水(0.9% NaCl)。通过对正常兔血浆进行超速离心,在密度范围1.063至1.25克/毫升获得HDL - VHDL组分。在整个研究过程中,两组的血浆脂质水平呈现相似的变化趋势。研究结束时,对照组主动脉内膜表面类似动脉粥样硬化的富含脂质病变覆盖面积为37.9±6%(X±SEM),治疗组为14.9±2.1%(p<0.001)。HDL - VHDL治疗组主动脉壁内沉积的总胆固醇、游离胆固醇、酯化胆固醇和磷脂的值显著低于对照组。治疗组肝脏中的胆固醇积累也显著低于对照组(p<0.01)。我们得出结论,给喂食胆固醇的兔子给予同源HDL - VHDL脂蛋白组分,可显著抑制主动脉脂肪条纹的程度,并降低动脉壁和肝脏中的脂质沉积,而不改变血浆脂质水平。